U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852975) titled 'GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma' on Sept. 23.
Brief Summary: This study is being done to see if a Ketogenic Diet (KD) or short-term Ketone supplement (KS) is feasible and safe for patients with recurrent Glioma who are undergoing a clinically indicated surgery.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Recurrent Glioma (Glioblastoma Multiforme)
Intervention:
DIETARY_SUPPLEMENT: Arm 1 will use Ketone supplement 80 gm daily
Arm 1 will use Ketone supplement 80 gm daily
OTHER...